FDA recall D-0875-2018

Allergan, PLC. · Class I · drug

Product

Allergan Taytulla Softgel Capsules, 1 mg/20 mcg, 6x28 blister card Physicians's Sample - Not for Sale Distributed by: Allergan USA INC Irvine, CA 92612 NDC 0023-5862-28 (Blister Card) NDC 0023-5862-29 (Blister Carton) NDC 0023-5862-31 (Outer carton) UPC 300235862290

Reason for recall

Contraceptive Tablets Out of Sequence.

Distribution

US Nationwide

Key facts

Status
Terminated
Initiation date
2018-05-24
Report date
2018-06-20
Termination date
2022-05-19
Voluntary/Mandated
Voluntary: Firm initiated
Location
Madison, NJ, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0875-2018